CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 93 enrolled
Drug / intervention
Survey of Decision Aidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04704193
NCT04704193N/ACompleted
CompareCT.gov

Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes

Massachusetts General Hospital·interventional·Posted Jan 11, 2021·Updated Aug 13, 2024

In Brief

A clinical study evaluating Survey of Decision Aid for Genetic Testing. Completed, enrolled 93 participants across 1 site.

Detailed Summary

An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGenetic Testing
CountriesUnited States
CollaboratorsBoston Medical Center, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 11, 2021
Enrollment StartNov 20, 2020
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 5.5 years ago

Interventions

Survey of Decision Aidother

The decision aid will be evaluated by a survey administered to those who have used the tool.